184 related articles for article (PubMed ID: 18989779)
1. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions and gastric cancer.
Zhuang W; Wu XT; Zhou Y; Liu GJ; Wu TX; Yao X; Du L; Wei ML
Dig Dis Sci; 2009 Jul; 54(7):1379-85. PubMed ID: 18989779
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis.
Mo A; Zhao Y; Shi Y; Qian F; Hao Y; Chen J; Yang S; Jiang Y; Luo Z; Yu P
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 28011897
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase genetic polymorphisms and cancer risk: a meta-analysis of 37 case-control studies.
Tang J; Wang PP; Zhuang YY; Chen WJ; Huang FT; Zhang SN
Chin Med J (Engl); 2012 Jul; 125(14):2582-8. PubMed ID: 22882943
[TBL] [Abstract][Full Text] [Related]
4. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
Graziano F; Kawakami K; Watanabe G; Ruzzo A; Humar B; Santini D; Catalano V; Ficarelli R; Merriman T; Panunzi S; Testa E; Cascinu S; Bearzi I; Tonini G; Magnani M
Int J Cancer; 2004 Dec; 112(6):1010-4. PubMed ID: 15386366
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans.
Yim DJ; Kim OJ; An HJ; Kang H; Ahn DH; Hwang SG; Oh D; Kim NK
Anticancer Res; 2010 Jun; 30(6):2325-30. PubMed ID: 20651387
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis.
Zhang Z; Xu Y; Zhou J; Wang X; Wang L; Hu X; Guo J; Wei Q; Shen H
Carcinogenesis; 2005 Oct; 26(10):1764-9. PubMed ID: 15930032
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.
Weng Y; Zhang J; Tang X; Xie X; Chen G
Leuk Lymphoma; 2012 Jul; 53(7):1345-51. PubMed ID: 22166040
[TBL] [Abstract][Full Text] [Related]
9. 2R of thymidylate synthase 5'-untranslated enhanced region contributes to gastric cancer risk: a meta-analysis.
Yang Z; Liu HX; Zhang XF
Asian Pac J Cancer Prev; 2012; 13(5):1923-7. PubMed ID: 22901148
[TBL] [Abstract][Full Text] [Related]
10. Control of glutamate receptor 2 (GluR2) translational initiation by its alternative 3' untranslated regions.
Irier HA; Quan Y; Yoo J; Dingledine R
Mol Pharmacol; 2009 Dec; 76(6):1145-9. PubMed ID: 19794129
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
Gao J; He Q; Hua D; Mao Y; Li Y; Shen L
Clin Transl Oncol; 2013 Aug; 15(8):619-25. PubMed ID: 23263912
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
[TBL] [Abstract][Full Text] [Related]
13. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma.
Zhang J; Cui Y; Kuang G; Li Y; Wang N; Wang R; Guo W; Wen D; Wei L; Yu F; Wang S
Carcinogenesis; 2004 Dec; 25(12):2479-85. PubMed ID: 15284183
[TBL] [Abstract][Full Text] [Related]
14. Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Mexican population.
Quintero-Ramos A; Gutiérrez-Rubio SA; Del Toro-Arreola A; Franco-Topete RA; Oceguera-Villanueva A; Jiménez-Pérez LM; Castro-Cervantes JM; Barragán-Ruiz A; Vázquez-Camacho JG; Daneri-Navarro A
Genet Mol Res; 2014 Oct; 13(4):8749-56. PubMed ID: 25366766
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
Kawakami K; Graziano F; Watanabe G; Ruzzo A; Santini D; Catalano V; Bisonni R; Arduini F; Bearzi I; Cascinu S; Muretto P; Perrone G; Rabitti C; Giustini L; Tonini G; Pizzagalli F; Magnani M
Clin Cancer Res; 2005 May; 11(10):3778-83. PubMed ID: 15897576
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment.
Baroudi O; Baroudi T; Omrane I; Moussa A; Mezlini A; Ayari H; Guermazi S; Bahloul A; Bouzaienne H; Uhrhammer N; Bignon YJ; El-Gaaied AB; Bougatef K
Med Oncol; 2014 Feb; 31(2):825. PubMed ID: 24415354
[TBL] [Abstract][Full Text] [Related]
17. The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis.
Wang J; Wang B; Bi J; Di J
Breast Cancer Res Treat; 2011 Jul; 128(1):203-9. PubMed ID: 21188629
[TBL] [Abstract][Full Text] [Related]
18. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the thymidylate synthase gene and risk of colorectal cancer.
Gao CM; Ding JH; Li SP; Liu YT; Cao HX; Wu JZ; Tajima K
Asian Pac J Cancer Prev; 2012; 13(8):4087-91. PubMed ID: 23098521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
